IRF8-regulated actions such as induction of genes that promote B cell formation, suppression of plasma cell formation, and promotion of apoptosis resistance likely contribute to the formation of DLBCL [132]. The gene discussed is IRF8; the disease is diffuse large B-cell lymphoma.